Jane Street Group, LLC Oramed Pharmaceuticals Inc. Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 59,659 shares of ORMP stock, worth $141,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,659

Previous 42,367 40.81%

Holding current value

$141,988

Previous $95,000 61.05%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.06 - $2.7 $35,621 - $46,688	17,292 Added 40.81%	59,659 $153,000
Q2 2025 Aug 14, 2025	SELL	$2.03 - $2.38 $50,356 - $59,038	-24,806 Reduced 36.93%	42,367 $95,000
Q1 2025 May 14, 2025	BUY	$2.0 - $2.62 $35,020 - $45,876	17,510 Added 35.26%	67,173 $143,000
Q4 2024 Feb 14, 2025	SELL	$2.17 - $2.52 $18,742 - $21,765	-8,637 Reduced 14.81%	49,663 $120,000
Q3 2024 Nov 14, 2024	BUY	$2.21 - $2.63 $4,928 - $5,864	2,230 Added 3.98%	58,300 $142,000

Q2 2024 Aug 14, 2024	SELL	$2.07 - $2.83 $62,832 - $85,901	-30,354 Reduced 35.12%	56,070 $144,000
Q1 2024 May 15, 2024	SELL	$2.18 - $3.58 $19,824 - $32,556	-9,094 Reduced 9.52%	86,424 $252,000
Q4 2023 Feb 14, 2024	BUY	$1.71 - $2.57 $144,676 - $217,437	84,606 Added 775.35%	95,518 $220,000
Q3 2023 Nov 14, 2023	SELL	$2.51 - $3.55 $71,818 - $101,576	-28,613 Reduced 72.39%	10,912 $28,000
Q2 2023 Aug 14, 2023	SELL	$2.12 - $4.47 $2,925 - $6,168	-1,380 Reduced 3.37%	39,525 $141,000
Q1 2023 May 15, 2023	SELL	$1.93 - $13.1 $177,729 - $1.21 Million	-92,088 Reduced 69.24%	40,905 $89,000
Q4 2022 Feb 14, 2023	BUY	$5.88 - $12.03 $535,127 - $1.09 Million	91,008 Added 216.76%	132,993 $1.6 Million
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $144,573 - $311,461	-31,429 Reduced 42.81%	41,985 $272,000
Q2 2022 Aug 16, 2022	BUY	$3.72 - $9.0 $162,173 - $392,355	43,595 Added 146.2%	73,414 $336,000
Q1 2022 May 17, 2022	SELL	$8.19 - $13.89 $257,337 - $436,437	-31,421 Reduced 51.31%	29,819 $258,000
Q4 2021 Feb 15, 2022	BUY	$12.98 - $29.75 $102,931 - $235,917	7,930 Added 14.88%	61,240 $875,000
Q3 2021 Nov 16, 2021	BUY	$12.13 - $23.82 $430,602 - $845,586	35,499 Added 199.31%	53,310 $1.17 Million
Q2 2021 Aug 16, 2021	BUY	$8.34 - $14.59 $148,543 - $259,862	17,811 New	17,811 $238,000
Q1 2021 May 18, 2021	SELL	$4.22 - $11.33 $85,628 - $229,897	-20,291 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$2.48 - $4.64 $30,861 - $57,740	-12,444 Reduced 38.01%	20,291 $86,000
Q3 2020 Nov 17, 2020	BUY	$2.58 - $4.16 $31,457 - $50,722	12,193 Added 59.36%	32,735 $85,000
Q2 2020 Aug 17, 2020	BUY	$2.87 - $4.12 $58,955 - $84,633	20,542 New	20,542 $73,000
Q1 2020 May 15, 2020	SELL	$2.6 - $5.5 $98,974 - $209,368	-38,067 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.43 - $5.74 $36,406 - $85,996	14,982 Added 64.9%	38,067 $196,000
Q3 2019 Nov 14, 2019	SELL	$2.88 - $3.96 $57,965 - $79,702	-20,127 Reduced 46.58%	23,085 $74,000
Q2 2019 Aug 15, 2019	BUY	$2.88 - $4.36 $124,450 - $188,404	43,212 New	43,212 $155,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Oramed Pharmaceuticals Inc. Transaction History